Status | Study |
Recruiting |
Study Name: Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo Condition: Adenoviral Conjunctivitis Date: 2016-12-16 Interventions: Drug: SHP640 Instill 1 drop of |
Completed |
Study Name: A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) Condition: Allergic Conjunctivitis Date: 2014-03-04 Interventions: Drug: Active Comparator EBI-005 5 mg/mL Dr |
Completed |
Study Name: Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis Condition: Bacterial Conjunctivitis Date: 2013-06-07 Interventions: Drug: Auriclosene Solution 0.3% |
Terminated |
Study Name: Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2013-05-20 Interventions: Drug: hydrocortisone ophthalmic ointment 0.5% |
Completed |
Study Name: Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis Condition: Conjunctivitis, Viral Date: 2013-02-22 Interventions: Drug: Ketorolac trometamol 0.45% with carboxymethylcellulose |
Completed |
Study Name: Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Condition: Allergic Conjunctivitis Date: 2012-09-27 Interventions: Drug: Olopatadine hydrochloride ophthalmic solution, 0.2% Other Name: PATADAY® |
Completed |
Study Name: An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients Condition: Bacterial Conjunctivitis Date: 2012-04-06 Interventions: Drug: Moxifloxacin ophthalmic solution, 0.5% |
Completed |
Study Name: Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis Condition: Adenoviral Conjunctivitis Date: 2012-02-09 Interventions: Drug: NVC-422 Solution, 0.3% N |
Active, not recruiting |
Study Name: Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients Condition: Ligneous Conjunctivitis Date: 2011-12-20 Interventions: Biological: Human Plasminogen Eye Drops |
Completed |
Study Name: Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model Condition: Allergic Conjunctivitis Date: 2011-11-22 Interventions: Drug: AL-4943A ophthalmic solution Drug: A |